Spruce Biosciences, Inc.
Statements
Cash Flow
Spruce Biosciences, Inc. (SPRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -8.6 | -13 | -28 | -36 | -42 | -33 | -56 | -33 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| 0.1 | 0.2 | 0.8 | 4.0 | 3.6 | 4.6 | 5.3 | 2.6 | |
| 0.1 | 0.2 | 0.8 | 4.4 | 3.7 | – | – | – | |
| 1.2 | 0.3 | 1.2 | 2.0 | 1.1 | 10 | -8.6 | -0.7 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | -0.1 | -79 | 24 | 56 | – | – | |
| – | – | – | 0.4 | – | 0.2 | – | – | |
| – | – | 93 | 0.1 | 0.0 | -0.3 | 0.1 | 0.0 | |
| 4.5 | 4.5 | 0.2 | 0.2 | 0.0 | -1.6 | -1.6 | -2.1 | |
| 12 | 12 | 181 | 0.6 | -0.2 | 49 | -1.6 | 43 | |
| -8.6 | -0.2 | 153 | -114 | -18 | 72 | -58 | 10 | |
| -8.6 | -13 | -28 | -36 | -42 | -33 | -56 | -33 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.